Schulman Bhattacharya is proud to announce the hiring of Renan Varghese, an accomplished litigator focused on commercial disputes, including employment litigation, class action litigation, wage and hour litigation, appellate litigation, sexual assault cases and police brutality cases. Mr. Varghese previously worked for one of the premier employment litigation firms in New York City, where he represented high profile clients across many industries, including sports, entertainment, and politics. Jeremy Schulman, Managing Member of Schulman Bhattacharya, stated: “We are very pleased... read more →

CNBC had published a lengthy piece about the Firm’s client, Marjorie Bloom, a retired federal government employee who lost her life savings to a common elder fraud scheme. The Firm is proud to have represented Ms. Bloom in the ensuing federal court litigation. The CNBC article, which has attracted nearly 1 million views, may be found by clicking here and here. Read the full story here View the PDF here

On March 3, 2023, the United States District Court for the District of Columbia issued a groundbreaking decision allowing Schulman Bhattacharya’s client, Marjorie Bloom, to proceed with her lawsuit against PNC Bank, N.A., in a ruling that has significant implications for the banking industry. Schulman Bhattacharya defeated PNC’s motion to dismiss, with the Court holding that PNC owed Ms. Bloom a contractual duty of care to investigate and intervene when faced with clear evidence of elder financial exploitation.... read more →

Schulman Bhattacharya secured another major victory last week for ExeGi Pharma, LLC and its flagship probiotic product, Visbiome. In ExeGi’s lawsuit against competitor Brookfield Pharmaceuticals, LLC, the United States District Court for the Eastern District of Wisconsin granted in part ExeGi’s motion for partial summary judgment, finding in ExeGi’s favor as to liability on its Lanham Act false advertising and common law unfair competition claims.  While ExeGi will go to trial to determine its damages, Judge J.P. Stadtmueller... read more →

Schulman Bhattacharya is very pleased to announce that Sabina Schiller has been elected a member of the Firm.  Ms. Schiller is the first lawyer to achieve this status since the Firm was founded in 2017. This accomplishment is based on Ms. Schiller’s invaluable contributions to the Firm, including playing a key role in many of the Firm’s largest and most complex client matters and contributing significantly to the Firm’s successful outcomes in numerous litigations through her remarkable advocacy, analytical... read more →

On September 23, 2022, Schulman Bhattacharya secured another victory for its client, Claudio De Simone, the inventor of the acclaimed probiotic product known as the De Simone Formulation.  The De Simone Formulation was formerly sold under the trademark VSL#3® and is now sold under the trademark Visbiome®.  In the recent court action, Professor De Simone prevailed again against VSL Pharmaceuticals, Inc., the owner of the VSL#3® trademark, and its licensees, Alfasigma USA, Inc., and Leadiant Biosciences, Inc. On... read more →

The United States Court of Appeals for the Fourth Circuit issued a unanimous, published decision today affirming yet another victory secured by Schulman Bhattacharya for its clients Claudio De Simone and ExeGi Pharma, LLC against Alfasigma USA, Inc. and VSL Pharmaceuticals, Inc. On July 30, 2020, Judge Theodore D. Chuang for the United States District Court of Maryland granted the Firm’s motion and held Alfasigma and VSL in civil contempt and sanctioned them for violating the Court’s permanent... read more →

On May 20, 2021, Schulman Bhattacharya filed a Complaint in the United States District Court for the Northern District of Georgia on behalf of ExeGi Pharma, LLC against Roberto Pacifici, a Professor of Medicine at the Emory University School of Medicine.  The suit asserted, among other things, a claim against Dr. Pacifici for Contributory False Advertising in violation of the Lanham Act arising out of a false advertising scheme facilitated by Dr. Pacifici that has damaged and continues... read more →

On October 19, 2021, Schulman Bhattacharya filed suit in the United States District Court for the Southern District of Florida on behalf of ExeGi Pharma, LLC, the distributor of the probiotic Visbiome®, against the Editor of the European Review for Medical and Pharmacological Services (ERMPS).  The lawsuit asserted that the Editor had used the journal “as a commercial tool fraudulently to advertise a second-rate medical product,” namely the VSL#3 probiotic.  The lawsuit further alleged that “by refusing to withdraw,... read more →

Schulman Bhattacharya is pleased to announce that Sabina Schiller and James “Jake” Schaller have been promoted to the position of Counsel. Sabina Schiller joined the Firm in 2018 as an associate attorney.  She worked previously for a well-known boutique commercial litigation firm, where she successfully represented major international corporations and high-net-worth individuals in all stages of complex commercial controversies in federal and state courts across the country.  Ms. Schiller earned her Juris Doctor from Emory University School of... read more →